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The architecture of the active site of members of the
protein tyrosine phosphatase (PTP) superfamily ren-
ders these enzymes sensitive to reversible oxidation
and inactivation. The importance of reversible oxida-
tion of PTP superfamily members in controlling the
signal output following an extracellular stimulus is
discussed.
Great progress has been made in defining phosphoryla-
tion-dependent signaling events that underlie physiologi-
cal responses to extracellular stimuli. Although initially
considered in terms of linear cascades of sequential
phosphorylation reactions that culminate in a particular
signaling outcome, it is now appreciated that the re-
sponses to stimuli comprise integrated networks of sig-
naling pathways that function in a precisely coordi-
nated manner. Control over these signaling networks is
exerted at the level of both phosphorylation and de-
phosphorylation, catalyzed by protein kinases and
phosphatases, respectively. Disturbance of this deli-
cate balance between kinase and phosphatase activity
has been shown to be a cause of human diseases in-
cluding cancer, diabetes, and inflammation. Therefore,
an understanding of the regulation and function of both
the kinases and phosphatases in the human proteome
is a prerequisite to defining the molecular mechanisms
that underlie signal transduction in health and disease
and ultimately to revealing opportunities for therapeu-
tic intervention.
Phagocytic cells, such as macrophages, contain a
multiprotein NADPH oxidase complex that produces a
burst of reactive oxygen species (ROS) as part of the
innate immune response to infection. NADPH oxidase
catalyzes the single electron reduction of molecular
oxygen to produce superoxide, which is rapidly con-
verted to H2O2. A family of NADPH oxidases has now
been identified in nonphagocytic cells, which produce
ROS in a regulated manner at lower levels than in
phagocytes, to control the signaling response to a wide
variety of physiological stimuli (Lambeth, 2004). H2O2 is
a small, neutral molecule that is readily produced and
removed following a physiological stimulus and can
freely diffuse through cellular membranes; thus, it ex-
hibits properties that are ideal for a regulator of signal-
ing (Finkel, 2003). A substantial body of literature now
points to the importance of regulated ROS production
as a new tier of control over tyrosine phosphorylation-
dependent signal transduction.
Reversible Oxidation and Inactivation of PTPs
As protein tyrosine phosphatases (PTPs) have become
established as critical regulators of signal transduction*Correspondence: tonks@cshl.eduin their own right, attention has been drawn to defining
how the activity of these enzymes can be regulated
in vivo. There arew100 human genes in the PTP super-
family, which rivals the diversity and complexity of the
family of PTKs. The PTP superfamily encompasses two
broad categories of enzymes: the classical pTyr-spe-
cific phosphatases and dual specificity phosphatases
(DSPs), which may also dephosphorylate Ser/Thr resi-
dues, and nonprotein substrates, such as inositol
phospholipids. The signature motif [I/V]HCXXGXXR[S/T],
which defines the PTP superfamily, contains an invariant
Cys residue, which functions as a nucleophile in catalysis.
Due to the unique chemical environment of the PTP active
site, this Cys residue displays an unusually low pKα,
which enhances its nucleophilic properties but renders
it susceptible to oxidation. Work from several labs has
demonstrated that PTPs are an important target of ROS
in the induction of an optimal tyrosine phosphorylation
response to a variety of physiological stimuli (Rhee et
al., 2003). Oxidation of the active site Cys abrogates its
nucleophilic properties, thereby inhibiting PTP activity.
Thus, one function of ROS produced following agonist
stimulation is to inactivate transiently the critical PTP(s)
that provide an inhibitory constraint upon the system,
thus facilitating the initiation of the signaling response
to that stimulus. Importantly, this mode of regulation
has the potential to represent a general feature of the
PTP superfamily as a whole.
A key element of a signaling response is reversibility.
For oxidation to represent a mechanism for reversible
regulation of PTP function, it is essential that the active
site Cys residue is not oxidized further than sulphenic
acid (S-OH); higher oxidation to sulphinic S-O2H or sul-
phonic S-O3H acid is usually irreversible. A crystallo-
graphic analysis of PTP1B showed that following oxi-
dation of the active site Cys to sulphenic acid, oxygen
is rapidly eliminated to produce a cyclic sulphenamide,
a 5-atom ring structure in which a covalent bond is
formed between the Cys sulfur atom and the main
chain nitrogen of the adjacent Ser residue (Salmeen et
al., 2003; van Montfort et al., 2003). This induces pro-
found changes in the architecture of the active site, in
which residues that are normally buried now adopt
solvent-exposed positions. These structural changes,
which are readily reversible in physiological reducing
agents, may serve a dual purpose; to protect the en-
zyme from higher-order, irreversible oxidation of the
active site Cys and, by exposing the oxidized Cys to
cellular reducing agents, to facilitate reduction back to
the active form of the enzyme. DSPs, such as cdc25
and PTEN, as well as the low Mr PTP, are also sensitive
to oxidation. Unlike the classical PTPs, these enzymes
contain a second Cys residue within the active site. Fol-
lowing oxidation of the nucleophilic cysteine within the
signature motif, a disulfide bond is formed with the vici-
nal Cys, which protects the enzymes from higher oxida-
tion and irreversible inactivation (Buhrman et al., 2005;
Lee et al., 2002). The S-S bond can be readily reduced,
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668ensuring the transient nature of the modification and
returning the enzymes to their active form.
There have been several reports of transient oxida-
tion and inactivation of specific PTPs in various signal-
ing contexts. Two recent papers have further empha-
sized the importance of this regulatory modification.
Regulation of BCR Signaling Output by Reversible
PTP Oxidation
Stimulation of a particular receptor can initiate multiple
signaling pathways. The challenge is to understand how
such pathways are coordinated and integrated, includ-
ing the establishment of feedback loops that ultimately
determine how the signal is propagated and the nature
of the physiological outcome. Rao’s lab have addressed
this issue in B lymphocytes (Singh et al., 2005). The
B cell antigen receptor (BCR) is a membrane bound,
multiprotein complex, comprising a ligand binding im-
munoglobulin, which is associated with a heterodimer
of Igα-Igβ (CD79a-CD79b) transmembrane proteins
that serve a signaling function. Antigen stimulation in-
duces BCR oligomerization and phosphorylation of ITAM
sequences (immune receptor, tyrosine-based activation
motif) in CD79a and b by the Src family PTK Lyn, which
recruits and activates Syk. This triggers a burst of phos-
phorylation and the activation of downstream signaling
components, such as PLCγ, which generates IP3 and
releases Ca2+ from intracellular stores. In their analysis,
Singh et al. have shown that the timing and extent of
the BCR-generated signal is determined by a feedback
loop between BCR-induced Ca2+ release and the pro-
duction of ROS. They noted two, largely distinct, waves
of BCR-induced phosphorylation, the first of which
peaked at 1 min before declining to baseline, followed
by the second, which reached a maximum by 10 min.
They also showed that ligation of the BCR induced two
phases of Ca2+ mobilization, first from the ER and then
via channels that promote influx of extracellular Ca2+.
Interestingly, inhibition of Ca2+ release from the ER at-
tentuated both waves of phosphorylation, whereas the
effects of inhibition of the second capacitative Ca2+ in-
flux were less pronounced. The authors concluded that
the intensity of the first phase of the phosphorylation
signal had a crucial impact on the extent and rate of
signal progression, which focused their attention on
proteins that act early in BCR signaling. They observed
that the phosphorylation and activation of Lyn, the Src
family PTK that initiates signaling, was dependent upon
Ca2+, particularly the ER pool. Thus BCR signaling trig-
gers Ca2+ release, which determines the proportion of
the Lyn population that becomes activated, which in
turn determines the extent and rate of protein phos-
phorylation. But what provides the link between Ca2+
and tyrosine phosphorylation? This is where ROS-
induced regulation of PTP function plays a critical role.
Stimulation of the BCR led to a rapid production of
ROS, in particular H2O2, which was dependent upon
PTK activity, PI 3 kinase function, and Ca2+. Interest-
ingly, suppression of BCR-induced ROS also attenu-
ated the mobilization of intracellular Ca2+, revealing a
positive feedback loop between ROS and Ca2+. The au-
thors demonstrated that H2O2 scavengers inhibited
BCR-induced Lyn phosphorylation and this was not
rescued by ionomycin-induced increases in Ca2+. Fur-
thermore, exogenous ROS enhanced the phosphoryla-
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iion of Lyn, but this was not attenuated by inhibition of
a2+ mobilization. This suggests that Lyn phosphoryla-
ion is regulated primarily by ROS and that Ca2+ influ-
nces the levels of ROS that are available for this effect.
CR-induced ROS production was sensitive to DPI (di-
henylene iodonium), an inhibitor of flavin-dependent
xygenases, implicating the Nox family. Indeed, using
NAi, they demonstrated that DUOX1 is critical for
CR-induced Lyn phosphorylation. The DUOX mem-
ers of the Nox family are characterized by the pres-
nce of Ca2+ binding, EF hand motifs that regulate oxi-
ase function. This is important because it indicates
hat BCR-induced Ca2+ mobilization directly regulates
xidase activity, providing the mechanistic link between
a2+ and ROS production.
The authors noted that BCR activation led to a rapid
nd transient inhibition of PTP activity that was associ-
ted with the receptor, which was blocked either by in-
ibition of Ca2+ mobilization or by antioxidants, and re-
ersed by treatment of the BCR immunoprecipitates
ith reducing agents. Most interestingly, stimulation of
he BCR in cells pretreated with a ROS scavenger re-
ulted in a dose-dependent decrease in ROS, which
oincided with a dose-dependent decrease in the ex-
ent of PTP inactivation and BCR-dependent Lyn phos-
horylation. Thus, the authors suggest that the extent
f PTP oxidation determines the activation status of
yn and, therefore, the signal output (Figure 1). As
HP-1 is known to interact directly with the BCR and
ttenuate signaling, it was considered as a target for
CR-induced ROS. Having confirmed the presence of
HP-1 in the BCR complex, the authors assumed, but
id not formally demonstrate, that this activity was due
o SHP-1. Interestingly, when they assayed the activity
f the cytosolic pool of SHP-1 directly following BCR
igation, it was not inhibited, which led them to suggest
hat the action of ROS was restricted to the pool of
HP-1 that was associated with the BCR. In the ab-
ence of interactions with pTyr sequences in signaling
eceptors, the SH2 domain-containing PTPs, such as
HP-1, adopt an inactive conformation in which their
ctive site is occluded by the N-terminal SH2 domain,
locking access to substrate, and presumably also to
OS, and rendering them inactive. Thus, it is not clear
hat activity the authors are measuring in these cyto-
olic samples. BCR stimulation also resulted in a rapid
nd transient inhibition of CD45, the prototypic recep-
or PTP, an effect that was ablated by Ca2+ antagonists
nd antioxidants. It will be important to clarify exactly
hich PTPs are susceptible to oxidation in the BCR
omplex. In addition, the authors show that ROS con-
inues to accumulate over a 5 min time course of BCR
igation, whereas maximal PTP inhibition was observed
ithin 30 s and had returned to baseline within 1 min.
t will also be of interest to define why oxidation is tran-
ient despite the continued production of ROS. Never-
heless, these data suggest that a Ca2+-ROS feedback
oop functions like a rheostat to tune BCR signal output
ia reversible PTP oxidation.
xidation of MAP Kinase Phosphatases
n TNFa-Induced Regulation of JNK
further example of this theme of coordinating signals
omes from a study in Michael Karin’s lab. TNFα, which
s a proinflammatory cytokine involved in the innate im-
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669Figure 1. Redox Regulation of PTPs Determines the Activation Status of the PTK Lyn, which in Turn Controls Signal Output from the B
Cell Receptormune response, triggers cell proliferation or cell death,
depending upon the signaling pathways that it en-
gages. The transcription factor NF-κB, which antago-
nizes the cell death response, is critical for this deci-
sion. In the presence of NF-κB, TNFα induces a rapid
and transient activation of the JNK MAP kinase; in con-
trast, in NF-κB-deficient cells TNFα induces sustained
JNK activation, which is a major determinant of cyto-
toxicity. ROS are critical second messengers in this
TNFα signaling response and the ability of NF-κB to
induce expression of a variety of target genes that an-
tagonize cell death by suppressing ROS production
provides a potential regulatory link with JNK activation.
So how does ROS promote JNK activation? Karin and
colleagues demonstrate that the MAP kinase phospha-
tase (MKP) subfamily of DSPs, which dephosphorylate
and inactivate JNK, are critical targets of ROS (Kamata
et al., 2005). Oxidation of MKPs leads to inactivation of
the phosphatases and thereby serves to sustain JNK
activation.
The authors noted that TNFα attenuated phospha-
tase activity toward JNK, an effect that was antago-
nized by the antioxidant BHA (butylated hydroxyani-
sole). Treatment of mice with Concanavalin A (ConA),
which induces TNFα and causes liver failure, resulted in
attenuated MKP activity and prolonged JNK activation.
When the mice were fed a diet supplemented with BHA,
JNK activation was decreased and ConA-induced liver
necrosis was suppressed. In light of this, the authors
focused their attention on the potential for regulation of
MKP activity by oxidation. As would be expected, they
demonstrated a dose-dependent oxidation of MKP-3
by H2O2 in vitro. However, one of most striking observa-
tions was that oxidation induced the formation of high
Mr oligomers of the various MKPs that were tested.
Comparison of the time course of JNK activation and
MKP aggregate formation reveals that JNK phosphory-
lation was maximal at 20 min and had returned to base-
line by 2 hr, whereas the formation of MKP aggregates
was barely detectable by 4 hr and maximal by 8 hr. This,
and the fact that aggregates were formed in vitro at
greater concentrations of H2O2 than necessary for inhi-
bition, suggests that aggregation may not directly re-
flect the oxidation-induced inhibition of MKP activitythat regulates the JNK pathway but rather a further
modification of the enzyme. Interestingly, yeast cyto-
solic peroxiredoxins (Prx) also undergo a shift from low
Mr to high Mr forms following oxidative stress of the
cells, inducing a functional change in Prx, from a perox-
idase to a chaperone, which helps the yeast cell adapt
to the stress response (Jang et al., 2004). It will be inter-
esting to investigate whether oligomerization also intro-
duces a novel function for the oxidized MKPs.
This study implicates oxidation-induced inhibition of
four MKPs in the mechanism by which TNFα-induced
JNK activation is sustained in NF-κB-deficient cells,
raising the issue of specificity. None of the MKPs tested
are specific regulators of JNK; all recognize other
MAPKs (Farooq and Zhou, 2004). In fact, MKP-3 is a
specific regulator of Erk. It will be particularly important
to identify the molecular targets of TNFα-induced ROS
under physiological conditions, including specifically
which MKPs are oxidized, and to explore whether NF-
κB also attenuates the activity of other MAPKs by this
mechanism. Another striking aspect of this study is the
sensitivity of TNFα-inducedROSproduction to expression
of MnSOD. This suggests that mitochondria are an im-
portant source of ROS in this context, consistent with
other reports of regulation of PTP function by mito-
chondrial ROS (Connor et al., 2005). These effects of
MnSOD were also observed late in the time course of
TNFα stimulation, raising questions of whether the
mitochondrial ROS are a cause or an effect of the com-
mitment to cell death. It will be interesting to explore
whether other ROS-generating systems contribute earlier
in the time course of TNFα-induced JNK activation.
Future Directions
These two exciting papers lend further support to the
physiological importance of PTP oxidation in determin-
ing the extent and duration of a signaling response. In
addition, for several receptor-PTPs, the membrane-dis-
tal PTP domain (D2) displays greater sensitivity to oxi-
dation than the catalytically active, membrane-proximal
PTP domain (D1). Oxidation induces a conformational
change in D2 that can be transmitted to the extracellu-
lar segment of the RPTP, resulting in stabilization of in-
active dimers (van der Wijk et al., 2004). Thus, D2 may
function as a redox sensor, registering ROS production
Cell
670in response to a stimulus by a conformational change
that induces a functional change in the RPTP and in
downstream signaling.
Despite such advances, significant challenges re-
main to be overcome before ROS gain universal accep-
tance as second messengers. Chief among these is to
change the perception of ROS, such as H2O2, from
agents of indiscriminate damage to specific regulators
of signaling. One element of such specificity is the tight
regulation of ROS production in response to a stimulus.
The activity of NADPH oxidases is controlled by phos-
phorylation of regulatory proteins and interaction with
the small GTPase RAC (Lambeth, 2004). As described
by Singh et al., another link to signaling is provided by
the regulation of the Duox enzymes by Ca2+. Thus, we
are beginning to understand at a mechanistic level how
signaling and ROS production may be integrated.
It will also be important to define precisely the source
and site of ROS production and to understand how
specificity of oxidation is achieved. Not all Cys residues
in proteins are susceptible to H2O2, which is a relatively
mild oxidant; it is only those that have a low pKα and
are present in the thiolate form at neutral pH that be-
come oxidized, in contrast to the bulk of Cys residues
in proteins for which the pKα is w8.5. Specificity has
already been demonstrated in the selective oxidation
of particular PTPs in response to physiological stimuli,
as in the case of PDGF-induced oxidation of SHP-2
(Meng et al., 2002) and insulin-induced oxidation of
PTP1B and TCPTP (Meng et al., 2004). Recent data
even suggest that there is differential sensitivity to oxi-
dation among PTP domains (Groen et al., 2005). Never-
theless, the conventional view of the orientation of Nox
enzymes presents somewhat of a challenge. For the
most part, Nox family members are localized on the
plasma membrane, with the H2O2 that is produced in
response to the stimulus being released extracellularly,
then diffusing locally into the cell. It will be important
to investigate to what extent this arrangement leads to
oxidation of reactive Cys residues in proteins other than
PTPs. This suggests that an important element of spec-
ificity is likely to be localization of the PTPs close to the
site of ROS production. An interesting recent develop-
ment in this context is the observation that Nox4, which
regulates ROS production in response to insulin and
the oxidation of PTP1B (Mahadev et al., 2004), colocal-
izes with PTP1B on intracellular membranes (Martyn et
al., 2005). There are several powerful antioxidants, such
as peroxiredoxin, that rapidly degrade H2O2, thereby re-
stricting its sphere of influence within the cell and con-
trolling its signaling potential. On the other hand,
studies to date have focused on tissue culture cells ex-
posed to an oxygen-rich environment. It will be impor-
tant to demonstrate that PTP oxidation occurs under
the lower physiological oxygen concentrations that are
encountered in tissues in the whole animal.
There has been considerable interest in PTPs as ther-
apeutic targets, particularly PTP1B for diabetes and
obesity. However, the highly charged active site in the
native enzymes, coupled with their susceptibility to oxi-
dation, has rendered the PTPs particularly challenging
targets for drug development. The changes in confor-
mation at the active site that accompany oxidation
in vitro generate a form of the PTP in which these prob-
l
s
T
d
c
i
c
s
o
i
s
P
s
a
f
e
f
d
S
B
(
C
w
J
1
F
F
G
O
B
J
L
6
K
M
L
L
(
M
C
B
M
a
M
M
(
R
J
S
T
S
K
v
C
v
(ematic properties are circumvented and new binding
urfaces for small molecule inhibitors are presented.
herefore, assuming such structural changes are in-
uced in vivo, stabilization of the oxidized, inactive
onformation of PTP1B, for example, may potentiate
nsulin signaling in a similar manner to inhibiting the
atalytically active form of the enzyme (analogous to
tabilization of inactive p210 Bcr-Abl by Gleevec) with-
ut having to resort to some of the highly charged PTP
nhibitors that have been reported to date. Also, if one as-
umes that oxidation targets the pool of the relevant
TP that is important for regulation of the signaling re-
ponse, then this strategy will target that pool specific-
lly, possibly also reducing complications of side ef-
ects that may accompany inhibition of the native
nzyme as a whole. It will be interesting to see whether
uture developments in our understanding of PTP oxi-
ation will ultimately yield new therapeutic strategies.
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